The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study. [electronic resource]
Producer: 20080527Description: 156-65 p. digitalISSN:- 0271-0749
- Adult
- Akathisia, Drug-Induced -- etiology
- Antidepressive Agents -- adverse effects
- Aripiprazole
- Citalopram -- adverse effects
- Cyclohexanols -- adverse effects
- Depressive Disorder, Major -- drug therapy
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Therapy, Combination
- Fatigue -- chemically induced
- Female
- Fluoxetine -- adverse effects
- Humans
- Male
- Middle Aged
- Paroxetine -- adverse effects
- Piperazines -- adverse effects
- Prospective Studies
- Psychiatric Status Rating Scales -- statistics & numerical data
- Quinolones -- adverse effects
- Sertraline -- adverse effects
- Single-Blind Method
- Time Factors
- Treatment Outcome
- Venlafaxine Hydrochloride
- Weight Gain -- drug effects
- Withholding Treatment -- statistics & numerical data
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.